Clinical Trials
5 trialsNCT00070070 2022-10-12
Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas
Ludwig Institute for Cancer Research
Phase 1 Completed
NCT01838200 2022-10-12
Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma
Ludwig Institute for Cancer Research
Phase 1 Terminated
NCT01498172 2015-02-04
BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients
University of Lausanne Hospitals
Phase 1 Completed
NCT00003184 2013-04-04
Vaccine Therapy in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003023 2013-01-18
Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed